Abstract
Abstract The beta-2 microglobulin at diagnosis has been reported to predict survival in diffuse large B-cell lymphoma (DLBCL) patients, but its prognostic significance remains controversial. We retrospectively analyzed 136 de novo DLBCL patients treated with R-CHOP in this study and found that a high beta-2 microglobulin correlated with older age, B symptoms, elevated LDH, advanced Ann Arbor stage and higher International Prognostic Index (IPI) score(p=0.034, p=0.002, p=0.018 and p Disclosures No relevant conflicts of interest to declare.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
